Work

Comparative LDL-C Lowering Efficacy of Nonstatin Therapies: Inclisiran Is Better Than Ezetimibe, PCSK9 Inhibitors, and Bempedoic Acid

Year: 2025

Type: article

Source: Journal of Cardiovascular Pharmacology

DOI: 10.1097/fjc.0000000000001731

Authors: Gaetano Santulli, Urna Kansakar, Stanislovas S. Jankauskas, Fahimeh Varzideh

Institutions: Albert Einstein College of Medicine, University of Naples Federico II

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute

Awards: Purposeful Outreach for Diversity and Inclusion of Underrepresented in Medicine (PODIUM) Physician-Scientists, G864706750

OpenAlex ID: W4411627231

FWCI: 2.591

Cites: 9

Cited by: 3

Related to: 10